Improperly issued drug patents can and do delay the entry of generic drugs. Indeed, a key strategy of brand-name pharmaceutical manufacturers is to obtain patents not just for active ingredients, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback